Steiner and colleagues demonstrated that 7/121 patients with schizophrenia were positive for anti-NMDA receptor IgA and/or IgM autoantibodies, but not IgG autoantibodies against NR1a (except NR1a/NR2b) [27]. Here, CD79A is linked to schizophrenia.